Lazard Asset Management
OM icon

Lazard Asset Management’s Outset Medical OM Stock Holding History

Lazard Asset Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,313
Closed -$1.81M – 2398
2024
Q2 		$1.81M Sell
31,313
-3,611
-10% -$177K ﹤0.01% 866
2024
Q1 		$1.16M Buy
34,924
+17,781
+104% +$900K ﹤0.01% 901
2023
Q4 		$1.39M Buy
17,143
+2,433
+17% +$198K ﹤0.01% 901
2023
Q3 		$2.4M Buy
14,710
+2,023
+16% +$477K ﹤0.01% 844
2023
Q2 		$4.16M Buy
12,687
+3,059
+32% +$933K 0.01% 741
2023
Q1 		$2.66M Buy
9,628
+9,394
+4,015% +$3.45M ﹤0.01% 863
2022
Q4 		$90K Buy
+234
New +$66K ﹤0.01% 1568

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Lazard Asset Management's OM Position: Q3 2024 in Review

Lazard Asset Management sold out of Outset Medical (OM) in Q3 2024, closing a stake of 31,313 shares — an estimated $1.81M sold.

Lazard Asset Management first reported a position in OM in Q4 2022 and held it in 7 quarters. The position peaked at $4.16M in Q2 2023. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

  • Lazard Asset Management reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
  • Lazard Asset Management sold 31,313 Outset Medical shares in Q3 2024, an estimated $1.81M.
  • Lazard Asset Management first reported a position in Outset Medical in Q4 2022 and held it in 7 quarters.
  • Lazard Asset Management's Outset Medical position peaked at $4.16M in Q2 2023.
  • 78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.